Prostate-specific Antigen: Its Usefulness in Clinical Medicine.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Trends in endocrinology and metabolism

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1043-2760(98)00082-4PMID 18406295
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy: Reply by authors

  1998cited by this paper
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998cited by this paper
• Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.

  1998cited by this paper
• Prostate-Specific Antigen or Human Kallikrein 3?

  1998cited by this paper
• Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

  1998cited by this paper
• Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy.

  1998cited by this paper
• Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features.

  1998cited by this paper
• Prostate-specific membrane antigen: current and future utility.

  1998cited by this paper
• Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer.

  1997cited by this paper
• Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

  1997cited by this paper
• Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.

  1997cited by this paper
• An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.

  1997cited by this paper
• Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.

  1997cited by this paper
• Prostate-specific antigen and early detection of prostate cancer.

  1997cited by this paper
• Consensus statement: Guidelines for PSA following radiation therapy

  1997cited by this paper
• Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts.

  1997cited by this paper
• Micrometastasis of prostate cancer to lymph nodes: detection by means of reverse transcription-polymerase chain reaction.

  1997cited by this paper
• Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen.

  1997cited by this paper
• A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.

  1997cited by this paper
• Clinical application of ultrasensitive prostate-specific antigen assays.

  1997cited by this paper
• Some comments on progress in the standardization of immunoassays for prostate-specific antigen.

  1997cited by this paper
• Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.

  1997cited by this paper
• Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.

  1997cited by this paper
• A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum.

  1997cited by this paper
• Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer.

  1996cited by this paper
• Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer (*)

  1996cited by this paper
• Clinical Chemistry 43:3 443–452 (1997) Molecular Pathology

  1996cited by this paper
• Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.

  1996cited by this paper
• Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers.

  1996cited by this paper
• Prostate specific antigen role and function

  1995cited by this paper
• Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

  1995cited by this paper
• The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.

  1995cited by this paper
• Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

  1995cited by this paper
• New biological functions of prostate-specific antigen?

  1995cited by this paper
• Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid.

  1995cited by this paper
• Prostate cancer, prostate-specific antigen, and the polymerase chain reaction.

  1995cited by this paper
• A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy.

  1994cited by this paper
• Screening for prostatic carcinoma with prostate specific antigen: results of the second year.

  1993cited by this paper
• Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.

  1993cited by this paper
• Prostate-specific antigen: biochemistry, analytical methods, and clinical application.

  1993cited by this paper
• Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.

  1993cited by this paper
• The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.

  1993cited by this paper
• Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

  1991cited by this paper
• A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

  1991cited by this paper
• Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique.

  1990cited by this paper
• Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.

  1987cited by this paper
• Purification of a human prostate specific antigen.

  1979cited by this paper
• Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification.

  1978cited by this paper
• Isolation and characterization of two specific antigens of human seminal plasma.

  1973cited by this paper
• [Some physico-chemical characteristics of " -seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII].

  1971cited by this paper

• Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review

  2024cites this paper
• Five historical innovations that have shaped modern urological surgery

  2023cites this paper
• Single-molecule immunoassay technology: Recent advances.

  2023cites this paper
• A novel approach to enhance the performance of kallikrein 6 enzyme using Pichia pastoris GS115 as a host

  2023cites this paper
• Expression of tissue PSA in breast cancer is associated with less aggressive disease and lower chance of tumor relapse

  2022cites this paper
• Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer

  2022cites this paper
• Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer

  2021cites this paper
• A STUDY ON CORRELATION OF SERUM PROSTATE SPECIFIC ANTIGEN WITH CLINICAL AND PATHOLOGICAL VARIABLES IN PATIENTS OF PROSTATOMEGALY

  2021cites this paper
• Prostate-Specific Antigen Levels Among Diabetic Men: Exploring Patients Attending Outpatient Clinic in Yemen

  2020cites this paper
• Clinical competence of serum miR-372 expression in diagnosing prostate cancer

  2020cites this paper
• Anti-PSMA monoclonal antibody increases the toxicity of paclitaxel carried by carbon nanotubes.

  2020cites this paper
• Can a Broad Molecular Screen Based on Circulating Tumor DNA Aid in Early Cancer Detection?

  2020cites this paper
• БІОХІМІЧНІ, Й АНАЛІТИЧНІ АСПЕКТИ

  2019influential citation
• Prostat-Specific Antigen: Biochemical, Molecular-Biological, and Analytical Aspects

  2019cites this paper
• Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis

  2019cites this paper
• Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer

  2019cites this paper
• Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women

  2017cites this paper
• Metal-enhanced fluorescent dye-doped silica nanoparticles and magnetic separation: A sensitive platform for one-step fluorescence detection of prostate specific antigen.

  2017cites this paper
• Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)

  2017cites this paper
• Serum level of prostate-specific antigen in diabetic patients in Basrah, Iraq

  2017cites this paper
• Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer

  2016cites this paper
• An integrated lab-on-a-chip-based electrochemical biosensor for rapid and sensitive detection of cancer biomarkers

  2016cites this paper
• Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping.

  2016cites this paper
• Concentration and purification of prostate cancer biomarkers envisaging an early diagnosis

  2016cites this paper
• Assessment of the risk of prostate cancer in adult smokers in Nnewi, Nigeria using prostate specific antigen as a biomarker

  2015cites this paper
• Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS.

  2015cites this paper
• Is Serum Prostate-specific Antigen a Diagnostic Marker for Benign and Malignant Breast Tumors in Women?

  2015cites this paper
• Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining

  2015cites this paper
• Cancer proteomics: developments in technology, clinical use and commercialization

  2015cites this paper
• Determination of prostate-specific antigen in serum samples using gold nanoparticle based amplification and lab-on-a-chip based amperometric detection

  2015cites this paper
• Measurement of prostate-specific antigen level as a biomarker for breast cancer by using mass signal amplification

  2015cites this paper
• Induction of cell death in prostate cancer cells by escopoletin, a promising treatment strategy

  2015cites this paper
• Mechanisms of Androgen-Independent Prostate Cancer

  2014cites this paper
• Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression

  2014cites this paper
• Advances in Plasmonic Technologies for Point of Care Applications

  2014cites this paper
• Application of ionic liquids in the concentration of cancer biomarkers

  2014cites this paper
• Detection of Cancer Biomarkers by Biosensors

  2014cites this paper
• IDENTIFYING MEDIATORS OF ANDROGEN-INDEPENDENT PROSTATE CANCER USING MASS SPECTROMETRY-BASED PROTEOMICS

  2014influential citation
• Matriptase mediated c-Met signaling in breast cancer

  2014cites this paper
• Seminal plasma as a diagnostic fluid for male reproductive system disorders

  2014cites this paper
• Structure-Based Drug Design of Diphenyl α-Aminoalkylphosphonates as Prostate-Specific Antigen Antagonists

  2014cites this paper
• Protein Tyrosine Kinase 7 (PTK7) as a Predictor of Lymph Node Metastases and a Novel Prognostic Biomarker in Patients with Prostate Cancer

  2014cites this paper
• Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC–MS/MS

  2014cites this paper
• Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation

  2014cites this paper
• Hierarchical clustering method to improve transrectal ultrasound-guided diffuse optical tomography for prostate cancer imaging.

  2014influential citation
• Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression*

  2013cites this paper
• A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

  2013cites this paper
• On‐capillary fluorescent labeling and capillary electrophoresis laser‐induced fluorescence analysis of glycoforms of intact prostate‐specific antigen

  2013cites this paper
• Cardiovascular health in men on androgen deprivation therapy for prostate cancer

  2013cites this paper
• Risk of prostate cancer and its correlation with different biochemical parameters in non diabetic men

  2013cites this paper
• Proteases in Cancer: Significance for Invasion and Metastasis

  2013cites this paper
• Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification.

  2012cites this paper
• Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer

  2012cites this paper
• Identifying cancer biomarkers by mass spectrometry‐based glycomics

  2012cites this paper
• Clinical evaluation of a novel method for the measurement of prostate‐specific antigen, AccuPSATM, as a predictor of 5‐year biochemical recurrence‐free survival after radical prostatectomy: results of a pilot study

  2012cites this paper
• Investigation of Novel Progression-related Methylation Events and HOXD Genes in Prostate Cancer

  2012cites this paper
• Acacia Honey Modulates Cell Cycle Progression, Pro-inflammatory Cytokines and Calcium Ions Secretion in PC-3 Cell Lines

  2012cites this paper
• Glycan alterations of serum proteins as tumour markers. Prostate-specific antigen in prostate cancer and acute-phase proteins in pancreatic cancer

  2011cites this paper
• Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

  2011cites this paper
• Serum Array; En metode for høykapasitetsanalyser av serumprøver

  2011cites this paper
• The rationale for early detection and treatment of brain tumors in survivors of childhood cancer

  2011cites this paper
• Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer

  2011cites this paper
• Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer

  2010cites this paper
• Identifizierung gering konzentrierter diagnostischer Glykoproteine in humanem Plasma mittels Affinitäts-Chromatographie und Massenspektrometrie

  2010cites this paper
• Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues

  2010cites this paper
• Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma

  2010influential citation
• Development of a sensitive detection method of cancer biomarkers in human serum (75%) using a quartz crystal microbalance sensor and nanoparticles amplification system.

  2010cites this paper
• The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.

  2009cites this paper
• Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.

  2008cites this paper
• Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.

  2008cites this paper
• Development of telomerase targeted gene therapy for treatment of cancer

  2008cites this paper
• Biochemical individuality reflected in chromatographic, electrophoretic and mass-spectrometric profiles.

  2008cites this paper
• Human kallikrein‐related peptidase 12: Antibody generation and immunohistochemical localization in prostatic tissues

  2007cites this paper
• Large‐scale protein identification of human urine proteome by multi‐dimensional LC and MS/MS

  2007cites this paper
• Expression and Functional Characterization of the Cancer-related Serine Protease, Human Tissue Kallikrein 14*

  2007cites this paper
• Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.

  2007cites this paper
• POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma?

  2007cites this paper
• Activity and stability of human kallikrein‐2‐specific linear and cyclic peptide inhibitors

  2007cites this paper
• Two-Dimensional Electrophoresis in Prostate Cancer Research and Diagnostics

  2007cites this paper
• Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples.

  2007cites this paper
• Alterations in the serum glycome due to metastatic prostate cancer.

  2007cites this paper
• HumanKallikrein-Related Peptidase 12 : AntibodyGeneration and Immunohistochemical Localization in ProstaticTissues

  2007cites this paper
• Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.

  2006influential citation
• Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers*

  2006influential citation
• Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer

  2006cites this paper
• Human tissue kallikrein 9: production of recombinant proteins and specific antibodies

  2006cites this paper
• Human Tissue Kallikrein 5 Is a Member of a Proteolytic Cascade Pathway Involved in Seminal Clot Liquefaction and Potentially in Prostate Cancer Progression*

  2006cites this paper
• Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status

  2006cites this paper
• Decreased kallikrein 11 messenger RNA expression in lung cancer.

  2006cites this paper
• Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression*

  2005cites this paper
• Intron retention: a common splicing event within the human kallikrein gene family.

  2005cites this paper
• Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.

  2005cites this paper
• A survey of alternative transcripts of human tissue kallikrein genes.

  2005cites this paper
• Glicosilació aberrant en proteïnes de secreció com a marcadors tumorals

  2004cites this paper
• Human tissue kallikreins: physiologic roles and applications in cancer.

  2004cites this paper
• Differential Expression of a Human Kallikrein 5 (KLK5) Splice Variant in Ovarian and Prostate Cancer

  2004cites this paper
• An update on human and mouse glandular kallikreins.

  2004cites this paper
• KINETIC CHARACTERIZATION OF hK6 INHIBITION BY PROTEASE INHIBITOR, SOYBEAN

  2004cites this paper
• Two step procedure for purification of enzymatically active prostate-specific antigen from seminal plasma.

  2004cites this paper
• Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

  2003cites this paper